[Spanish]
Wednesday, 31 January 2018
Wednesday, 24 January 2018
Re-irradiação esplénica em doente com leucemia linfocítica crónica B - caso clínico (Portuguese) (splenic re-irradiation in patient with chronic lymphocytic leukemia B - clinical case)
Carcinoma de células de Merkel - risco-benefício da radioterapia em estádios avançados (Portuguese) (Merkel cell carcinoma - benefit-risk of radiotherapy in advanced stage)
Wednesday, 17 January 2018
Cost-Effectiveness of Primary Radiation Therapy Versus Radical Prostatectomy for Intermediate- to High-Risk Prostate Cancer
Cost-Effectiveness of Primary Radiation Therapy Versus Radical Prostatectomy for Intermediate- to High-Risk Prostate Cancer: To compare, using a cost-effectiveness analysis, the quality-adjusted life expectancy
(QALE) and cost between the 2 treatment options for intermediate- to high-risk prostate
cancer: (1) radiation (RT) with androgen deprivation therapy (ADT) or (2) radical
prostatectomy (RP) followed by adjuvant RT for patients with risk factors.
(QALE) and cost between the 2 treatment options for intermediate- to high-risk prostate
cancer: (1) radiation (RT) with androgen deprivation therapy (ADT) or (2) radical
prostatectomy (RP) followed by adjuvant RT for patients with risk factors.
Subscribe to:
Posts (Atom)